Skip to main navigation Skip to search Skip to main content

UB CAT: Development of novel therapeutic IpY for ER/PR+, HER2- breast cancer: optimizing nanoparticle delivery and leveraging big data for precision treatment

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/19 → 06/30/20

Funding

  • Concarlo Holdings LLC: $103,760.38